Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay
about
GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsComparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutationsMutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant TuberculosisIncreased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests.Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South AfricaA standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.Nanowire sensors monitor bacterial growth kinetics and response to antibiotics.
P2860
Q28068545-C8E91AF1-7018-4829-8AAA-F15D20A3C17EQ30276393-0301E7A1-4EB5-48D3-A900-A19231E7E512Q36165509-046781EB-68B3-4310-AC02-864D8E5D1287Q36730001-2B0CA6E0-6577-4004-BEA0-0A8EA7B64D71Q37120071-48CCA9CA-1693-40F9-B48F-F6BD000C4517Q38839490-0C644E7D-9FB0-4994-95B5-449383DD9DA2Q39412049-EC8EF5E8-76BE-4996-9450-087EDD74010BQ40043590-2A2CAA5C-2247-40BA-A75B-06C37515AA5CQ40409813-A1C4F061-D245-4DAA-8047-5F772487674CQ47237569-017A790E-4EFB-4F6F-B69E-488C681CABC6Q47632774-4F11CC72-C88A-4703-A21E-0557B7721E17Q50101557-40152AD6-FECC-47B0-8885-945FC4D35FDF
P2860
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@ast
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@en
type
label
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@ast
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@en
prefLabel
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@ast
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@en
P2093
P2860
P1433
P1476
Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay
@en
P2093
Anjali Shetty
Antonino Catanzaro
Camilla Rodrigues
Chaitali Nikam
Kanchan Ajbani
Meeta Sadani
Priti Kambli
Timothy C Rodwell
Zarir Udwadia
P2860
P304
P356
10.1016/J.TUBE.2014.11.003
P577
2014-12-03T00:00:00Z